Study: Wegovy, Ozempic Lower Risk of Many Obesity-Related Cancers

Source: US News & World Report

“In yet another finding that touts the health benefits of wildly popular weight-loss medications like Wegovy and Ozempic, scientists report that taking the drugs may help reduce the risk of some cancers. In a study published July 5 in JAMA Network Open, researchers found people with type 2 diabetes who were being treated with a class of GLP-1 drugs were less likely to be diagnosed with 10 of 13 obesity-linked cancers than those who were taking insulin. The reduction in risk was significant: Taking the medications cut rates of gallbladder cancer, meningioma, pancreatic cancer and hepatocellular carcinoma, a type of liver cancer, by more than half. Risks were also reduced for cancers of the ovaries, colon, esophagus and kidneys as well as for multiple myeloma (a cancer of the bone marrow) and endometrial cancer (which begins in the lining of the uterus).” (07/08/24)